Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Mar;6(3):358-71.
doi: 10.1002/emmm.201303404. Epub 2014 Jan 13.

A potent anti-dengue human antibody preferentially recognizes the conformation of E protein monomers assembled on the virus surface

Affiliations

A potent anti-dengue human antibody preferentially recognizes the conformation of E protein monomers assembled on the virus surface

Guntur Fibriansah et al. EMBO Mol Med. 2014 Mar.

Abstract

Dengue virus (DENV), which consists of four serotypes (DENV1-4), infects over 400 million people annually. Previous studies have indicated most human monoclonal antibodies (HMAbs) from dengue patients are cross-reactive and poorly neutralizing. Rare neutralizing HMAbs are usually serotype-specific and bind to quaternary structure-dependent epitopes. We determined the structure of DENV1 complexed with Fab fragments of a highly potent HMAb 1F4 to 6 Å resolution by cryo-EM. Although HMAb 1F4 appeared to bind to virus and not E proteins in ELISAs in the previous study, our structure showed that the epitope is located within an envelope (E) protein monomer, and not across neighboring E proteins. The Fab molecules bind to domain I (DI), and DI-DII hinge of the E protein. We also showed that HMAb 1F4 can neutralize DENV at different stages of viral entry in a cell type and receptor dependent manner. The structure reveals the mechanism by which this potent and specific antibody blocks viral infection.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The mechanism of HMAb 1F4 neutralization of DENV1 (Western Pacific 74 strain) in Vero or DC-SIGN expressing U937 cell lines. A, B Both HMAb 1F4 IgG (A) and its Fab fragment (B) neutralized DENV1 infection in U937 cells expressing DC-SIGN although the Fab fragment required a 4-fold higher concentration. C HMAb 1F4 inhibited a post-attachment step of virus infection in Vero cells. HMAb 1F4 had similar neutralization activities when exposed to virus pre- (FRNT50 = 0.41 μg/ml) or post-attachment (FRNT50 = 0.37 μg/ml) to Vero cells. The two experiments were done with two replicates. Error bars represent standard deviations. Pre and post-attachment neutralization curves are not significantly different by a 2-way repeated measures analysis of variance (RM ANOVA). D HMAb 1F4 prevented virus infection of DC-SIGN-expressing U937 cells by blocking both virus attachment and also a post-attachment step. Error bar represented standard deviations. Neutralization curves of pre and post-attachment groups are significantly different by 2-way RM ANOVA, with a P < 0.001.
Figure 2
Figure 2
Prophylactic efficacy of HMAb 1F4 in DENV1-inoculated AG129 mice. A, B Mice were administered 20 μg of HMAb 1F4 or 50 μg IgG1 isotype control 24 h prior to a sub-lethal dose of 5 × 106 pfu of DENV1 Western Pacific 74. Serum viremia (A) and bone marrow viral load (B) were determined 3 days post-infection by qRT-PCR. One representative experiment of two is shown, with n = 4 mice per group. DENV1 limit of detection is indicated by the dashed line. *P = 0.0209 compared to IgG1 control, as determined using a 2-tailed Wilcoxon Rank Sum test.
Figure 3
Figure 3
The cryo-EM structure of Fab 1F4 complexed with DENV1.
  1. Cryo-EM map of Fab 1F4 complexed with DENV1 showed 120 copies of Fab (blue) bound to the virus surface (cyan). White triangle indicates an icosahedral asymmetric unit and the numbers represents the vertices.

  2. Cross-section of a quarter of a cryo-EM map.

  3. The resolution of the cryoEM map is 6 Å. Regions of the density map corresponding to trans-membrane α-helices (left) and β-strands (right).

  4. The density map corresponding to Fab 1F4. The density of the constant region (indicated by arrow) is much poorer than the variable region indicating the constant region is flexible.

Figure 4
Figure 4
The epitope bound by Fab 1F4.
  1. Densities of Fab 1F4 on E proteins in two icosahedral asymmetric units. Fab 1F4 molecules bind to molecules A and B in each asymmetric unit.

  2. Open-book representation of Fab 1F4 binding to E protein. The E protein DI, DII and DIII are colored in red, yellow and blue (top), respectively, whereas the Fab 1F4 heavy and light chains are colored in green and cyan (bottom), respectively. The epitope bound by Fab 1F4 is located on the DI and DI-II hinge regions (top). The epitope on E protein bound by the heavy and light chain are colored in green and cyan, respectively (top). Also the epitope on DI that interacted with both heavy and light chains are colored in purple (top). The paratope on heavy and light chain (bottom) are colored in its corresponding interacting residues on the DI (red) and DII (yellow) E protein, paratope binding to both DI and II on the E protein is colored in pink.

  3. Ribbon representation of the HMAb 1F4 epitope on E protein (top) and also sequence alignment of the epitope region between all dengue virus serotypes (bottom). The β-strand and loop of the epitope are colored in orange and black, respectively (top). In the bottom panel, the secondary structures are shown above the amino acid sequence. The amino acid residues that interact with Fab 1F4 are highlighted in the same coloring scheme as in (B). The amino acid sequences are derived from DENV1 strain PVP159, DENV2 strain S16803, DENV3 strain Thailand 1995 and DENV4 strain Dominica 1981.

Figure 5
Figure 5
Interaction interface between Fab 1F4 and DENV1 E protein.
  1. Open-book representation showing the electrostatic potential of the interaction interface on the E protein (left) and the Fab 1F4 (right). The blue and red colors indicate positive and negative charges, respectively, whereas the white color shows neutral charge. The dotted lines indicate the border of the footprint between heavy and light chains on the E protein epitope (left) and also the corresponding border on the antibody paratope (right). Residues on E protein identified in the neutralization escape mutants (K47 and G274) are indicated, together with other residues that have opposite charges in other serotypes. The corresponding interacting residues on the Fab 1F4 light and heavy chains are indicated with cyan and green colored fonts, respectively.

  2. Table of the list of putative interactions between DENV1 and Fab 1F4.

Figure 6
Figure 6
Fab 1F4 also has non-CDR related interactions with glycan chains on N153 on the same E protein and the N67 of a neighboring E protein. Left and right panels show different views of these interactions.The heavy and light chains of Fab 1F4 are colored in green and cyan, respectively, whereas the E protein molecules A and C' are in beige and gray, respectively (see Fig 4A for reference). The oxygen and nitrogen atoms of the glycan chains are colored in red and blue, respectively.
Figure 7
Figure 7
Analysis of the accessibility of the epitope on all three individual E protein molecules in an asymmetric unit. A Superposition of the three individual E protein molecules in an asymmetric unit (molecules A–C). The epitope location is indicated by a rectangular box. Molecules A, B and C in each asymmetric unit are colored in yellow, red and gray, respectively. The E proteins have similar conformation indicating that the lack of Fab binding to molecule C is mainly due to the blockage of the epitope by a neighboring E protein molecule. B–D Molecules A, B, and C in each asymmetric unit are colored in yellow, red and gray, respectively. The epitope is colored in the same coloring scheme as in Fig 4B. The epitopes on molecules A (B) and B (C) (circled) are fully accessible. (D) In contrast, the part of the epitope on molecule C is blocked by DIII of a neighboring E protein (indicated by arrow). For clarity, one of the E proteins (left) is represented as a transparent surface to show the hidden part of an adjacent epitope (marked by*).
Figure 8
Figure 8
Comparison of epitopes bound by HMAb 1F4 (left), HMAb14c10 (middle) and 5H2 (right). The epitopes are colored in green.
Figure 9
Figure 9
Comparison of the DI-DII hinge angle of the crystal structures of rE protein with the cryo-EM structures of virus E protein.
  1. Superposition of the crystal structures of rE and the subnanometer resolution cryo-EM structures of virus E proteins showed that the hinge angles of rE proteins are variable whereas those on the virus surface are largely conserved. DI of these structures was superimposed using ‘LSQ superpose’ in COOT (Emsley et al, 2010).

  2. Zoom-in view of the part of the HMAb 1F4 epitope that consists of the kl loop (represented as sticks) in the DI-II hinge region. The kl loops from the viruses (left) showed conserved conformation whereas those from the rE proteins (right) showed varying conformations. Residue 274, which is critical for HMAb 1F4 binding (De Alwis et al, 2012), is shown as a sphere.

None
Possible neutralization mechanisms by HMAb 1F4.
  1. HMAb 1F4 may block DC-SIGN from binding to the glycosylation site on N67. One DC-SIGN molecule binds across two N67 glycans on the virus surface. When Fab 1F4 is allowed to bind to the virus surface, it engages the N67 glycan on molecule B. This would cause steric hindrance thereby preventing the virus from binding to DC-SIGN on the surface of dendritic cells (Pokidysheva et al, 2006). Superposition of the cryo-EM complex structures of DENV1-Fab 1F4 and the DENV2-carbohydrate recognition domain (CRD) of DC-SIGN (PDB code 2B6B) showed that the Fab and the CRD molecules clashed. This indicates that simultaneous binding of these molecules on the virus surface is not possible. E protein molecules A, B and C are colored in light gray and molecules A’, B’ and C’ in gray. DC-SIGN is shown as a transparent orange surface. The glycosylation sites on N67 and N153 are marked as red stars and blue squares, respectively. The clashes between the Fab and DC-SIGN molecules are indicated by arrows.

  2. Fab 1F4 may interfere with the E protein dimer to trimer structural changes during fusion of the virus to the endosomal membrane. (i) The DI-DII hinge of the whole virus E protein has a different angle compared to the crystal structure of the trimeric post- fusion rE protein. This suggests that the binding of HMAb 1F4 to virus may lock the E protein hinge thus preventing the kl loop from undergoing structural changes to the post-fusion structure. The E protein on the virus and the post-fusion trimeric state are colored in blue and pink, respectively. (ii) Superposition of the cryo-EM Fab 1F4-DENV1 E protein structure onto the post-fusion trimeric E protein crystal structure. The Fab 1F4 molecule clashed with DIII of a neighboring E protein in the post-fusion trimeric structure (indicated by arrow). Two molecules of E protein are shown as surfaces (colored in light gray and dark gray) and one molecule is shown as ribbons. Fab 1F4 is drawn as a transparent surface.

References

    1. Arnold K, Bordoli L, Kopp J, Schwede T. The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling. Bioinformatics. 2006;22:195–201. - PubMed
    1. Austin SK, Dowd KA, Shrestha B, Nelson CA, Edeling MA, Johnson S, Pierson TC, Diamond MS, Fremont DH. Structural basis of differential neutralization of DENV-1 genotypes by an antibody that recognizes a cryptic epitope. PLoS Pathog. 2012;8:e1002930. - PMC - PubMed
    1. Baker NA, Sept D, Joseph S, Holst MJ, McCammon JA. Electrostatics of nanosystems: application to microtubules and the ribosome. Proc Natl Acad Sci USA. 2001;98:10037–10041. - PMC - PubMed
    1. Balsitis SJ, Williams KL, Lachica R, Flores D, Kyle JL, Mehlhop E, Johnson S, Diamond MS, Beatty PR, Harris E. Lethal antibody enhancement of dengue disease in mice is prevented by Fc modification. PLoS Pathog. 2010;6:e1000790. - PMC - PubMed
    1. Beltramello M, Williams KL, Simmons CP, Macagno A, Simonelli L, Quyen NT, Sukupolvi-Petty S, Navarro-Sanchez E, Young PR, de Silva AM, et al. The human immune response to Dengue virus is dominated by highly cross-reactive antibodies endowed with neutralizing and enhancing activity. Cell Host Microbe. 2010;8:271–283. - PMC - PubMed

Publication types

MeSH terms